Published in World J Surg on August 01, 2015
Incidental and non-incidental thyroid microcarcinoma. Oncol Lett (2016) 0.75
Papillary and follicular thyroid carcinoma. N Engl J Med (1998) 4.95
Thyroid carcinoma. Lancet (2003) 4.08
Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg (1995) 2.00
Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet (1999) 1.98
Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg (2002) 1.56
Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope (2004) 1.56
Pathology and genetics of thyroid carcinoma. J Surg Oncol (2006) 1.45
Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery (2008) 1.38
Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid (2010) 1.33
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery (2000) 1.22
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer (2008) 1.22
Familial thyroid cancer. Curr Opin Oncol (2001) 1.21
Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol (2008) 1.15
Does familial non-medullary thyroid cancer adversely affect survival? World J Surg (2006) 1.15
Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery (2008) 1.15
Carcinoma of the thyroid and other diseases of the thyroid in identical twins. AMA Arch Surg (1955) 1.15
An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg (2007) 1.14
Familial nonmedullary thyroid cancer. Thyroid (2005) 1.04
Familial thyroid carcinoma: a diagnostic algorithm. Adv Anat Pathol (2008) 0.97
Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab (2010) 0.92
An update on papillary microcarcinoma. Curr Opin Oncol (2009) 0.91
Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg (2004) 0.84
Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) (2004) 1.96
Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy. Clin Endocrinol (Oxf) (2005) 1.95
Endoscopic thyroidectomy using a new bilateral axillo-breast approach. World J Surg (2007) 1.88
Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) (2004) 1.87
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2006) 1.77
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74
Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2004) 1.44
The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) (2005) 1.35
Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol (2012) 1.34
Endoscopic thyroidectomy for thyroid malignancies: comparison with conventional open thyroidectomy. World J Surg (2007) 1.30
18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope (2005) 1.28
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2009) 1.27
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) (2004) 1.24
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2008) 1.23
Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience. Endocr J (2013) 1.16
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol (2013) 1.16
18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab (2007) 1.11
Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg (2007) 1.08
Endoscopic thyroidectomy via bilateral axillo-breast approach (BABA): review of 512 cases in a single institute. Surg Endosc (2011) 1.06
Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res (2004) 1.04
Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol (2008) 1.04
Knowledge, attitudes, risk perception, and cancer screening behaviors among cancer survivors. Cancer (2011) 1.01
Technical and oncologic safety of robotic thyroid surgery. Ann Surg Oncol (2013) 1.01
Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene. J Mol Med (Berl) (2004) 1.00
Comparison of conventional, nested, and real-time PCR assays for rapid and accurate detection of Vibrio vulnificus. J Clin Microbiol (2008) 1.00
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid (2012) 1.00
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol (2013) 0.99
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan. J Clin Endocrinol Metab (2010) 0.95
Overexpression of betaPix-a in human breast cancer tissues. Cancer Lett (2003) 0.95
Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma. Endocr J (2005) 0.95
Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci (2012) 0.95
Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma. Eur J Endocrinol (2013) 0.95
Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck (2007) 0.94
Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system. Am J Clin Pathol (2010) 0.94
Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf) (2010) 0.94
Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy. Thyroid (2013) 0.93
Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm". Korean J Intern Med (2003) 0.92
Knowledge, attitudes, and practice on second primary cancer screening among cancer survivors: a qualitative study. Patient Educ Couns (2010) 0.92
Diagnosis of thyroid follicular neoplasm: fine-needle aspiration versus core-needle biopsy. Thyroid (2014) 0.91
Identification of angiogenesis in primary breast carcinoma according to the image analysis. Breast Cancer Res Treat (2002) 0.90
Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells. Anticancer Res (2005) 0.90
Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography. J Ultrasound Med (2014) 0.89
Primary malignant teratoma with a primitive neuroectodermal tumor component in thyroid gland: a case report. J Korean Med Sci (2007) 0.89
Surgical outcomes of robotic thyroid surgery using a double incision gasless transaxillary approach: analysis of 400 cases treated by the same surgeon. Head Neck (2013) 0.88
Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer (2008) 0.88
Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study. Clin Endocrinol (Oxf) (2003) 0.88
Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer. Thyroid (2013) 0.88
Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population. Thyroid (2013) 0.87
Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. Ann Surg Oncol (2014) 0.87
Thyroid nodules with initially non-diagnostic, fine-needle aspiration results: comparison of core-needle biopsy and repeated fine-needle aspiration. Eur Radiol (2014) 0.87
Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma. Laryngoscope (2006) 0.87
Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma. Nucl Med Commun (2011) 0.86
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers. Surgery (2008) 0.85
Ultrasound features of suture granulomas in the thyroid bed after thyroidectomy for papillary thyroid carcinoma with an emphasis on their differentiation from locally recurrent thyroid carcinomas. Ultrasound Med Biol (2009) 0.85
Epidermal growth factor receptor status in anaplastic thyroid carcinoma. J Clin Pathol (2006) 0.85
Time trend in tumour size and characteristics of anaplastic thyroid carcinoma. Clin Endocrinol (Oxf) (2012) 0.84
Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. J Surg Oncol (2013) 0.84
The current status of endoscopic thyroidectomy in Korea. Surg Laparosc Endosc Percutan Tech (2008) 0.84
A case of recurrent pulmonary inflammatory myofibroblastic tumor with aggressive metastasis after complete resection. Tuberc Respir Dis (Seoul) (2013) 0.84
Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13. World J Surg (2008) 0.84
Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol (2014) 0.83
Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol (2006) 0.83
DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma. Anticancer Res (2013) 0.82
A case of ACTH-producing pheochromocytoma associated with pregnancy. Endocr J (2003) 0.82
Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation. J Clin Endocrinol Metab (2011) 0.81
Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. J Clin Endocrinol Metab (2015) 0.81
Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2014) 0.81
A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma. Clin Endocrinol (Oxf) (2014) 0.81
Efficacy of an educational material on second primary cancer screening practice for cancer survivors: a randomized controlled trial. PLoS One (2012) 0.80
Optimal timing of surgery in well-differentiated thyroid carcinoma detected during pregnancy. J Surg Oncol (2005) 0.80
Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk. Anticancer Res (2004) 0.79
Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer. Endocr J (2008) 0.79
Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation. Clin Endocrinol (Oxf) (2010) 0.79
CpG methylation of the ERalpha and ERbeta genes in breast cancer. Int J Mol Med (2004) 0.77
Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder. J Korean Med Sci (2011) 0.77
The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Radiat Oncol (2010) 0.77